HEADER TRANSFERASE/INHIBITOR 21-NOV-22 8F8E TITLE CRYSTAL STRUCTURE OF THE WDR DOMAIN OF HUMAN DCAF1 IN COMPLEX WITH TITLE 2 OICR-8268 COMPOUND COMPND MOL_ID: 1; COMPND 2 MOLECULE: DDB1- AND CUL4-ASSOCIATED FACTOR 1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HIV-1 VPR-BINDING PROTEIN,VPRBP,SERINE/THREONINE-PROTEIN COMPND 5 KINASE VPRBP,VPR-INTERACTING PROTEIN; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: DCAF1, KIAA0800, RIP, VPRBP; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PFBOH-MHL KEYWDS WD-REPEAT, WDR, DCAF1, SGC, TRANSFERASE, STRUCTURAL GENOMICS, KEYWDS 2 STRUCTURAL GENOMICS CONSORTIUM, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.KIMANI,A.LI,A.DONG,Y.LI,A.HUTCHINSON,A.SEITOVA,B.WILSON,R.AL-AWAR, AUTHOR 2 M.VEDADI,P.BROWN,C.H.ARROWSMITH,A.M.EDWARDS,L.HALABELIAN,STRUCTURAL AUTHOR 3 GENOMICS CONSORTIUM (SGC) REVDAT 1 01-MAR-23 8F8E 0 JRNL AUTH S.KIMANI,A.LI,A.DONG,Y.LI,A.HUTCHINSON,A.SEITOVA,B.WILSON, JRNL AUTH 2 R.AL-AWAR,M.VEDADI,P.BROWN,C.H.ARROWSMITH,A.M.EDWARDS, JRNL AUTH 3 L.HALABELIAN JRNL TITL CRYSTAL STRUCTURE OF THE WDR DOMAIN OF HUMAN DCAF1 IN JRNL TITL 2 COMPLEX WITH OICR-8268 COMPOUND JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.55 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0258 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 44.08 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 3 NUMBER OF REFLECTIONS : 86348 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.182 REMARK 3 R VALUE (WORKING SET) : 0.181 REMARK 3 FREE R VALUE : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1744 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.59 REMARK 3 REFLECTION IN BIN (WORKING SET) : 6249 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.27 REMARK 3 BIN R VALUE (WORKING SET) : 0.2730 REMARK 3 BIN FREE R VALUE SET COUNT : 118 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4620 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 71 REMARK 3 SOLVENT ATOMS : 327 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 22.97 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.83000 REMARK 3 B22 (A**2) : 0.12000 REMARK 3 B33 (A**2) : -0.53000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.50000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.079 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.080 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.060 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.702 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.968 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.958 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4938 ; 0.007 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 4299 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6745 ; 1.421 ; 1.630 REMARK 3 BOND ANGLES OTHERS (DEGREES): 9977 ; 1.368 ; 1.576 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 625 ; 7.822 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 250 ;33.761 ;23.240 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 763 ;12.096 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;11.698 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 661 ; 0.068 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5843 ; 0.007 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1081 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2426 ; 1.766 ; 2.361 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 2423 ; 1.765 ; 2.360 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3039 ; 2.789 ; 3.534 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 3039 ; 2.790 ; 3.534 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2512 ; 2.249 ; 2.588 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 2509 ; 2.248 ; 2.586 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 3695 ; 3.492 ; 3.790 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 5136 ; 4.956 ;28.019 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 5086 ; 4.917 ;27.844 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : NULL REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 0 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 LOOSE POSITIONAL 1 B (A): 14 ; 0.01 ; 5.00 REMARK 3 TIGHT THERMAL 1 B (A**2): 18 ; 3.16 ; 0.50 REMARK 3 LOOSE THERMAL 1 B (A**2): 14 ; 2.41 ; 10.00 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8F8E COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 23-NOV-22. REMARK 100 THE DEPOSITION ID IS D_1000270110. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-APR-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97918 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : HKL-3000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 88118 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 5.300 REMARK 200 R MERGE (I) : 0.06500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 27.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.58 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.74800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.880 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 4PXW REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 0.2M DI-AMMONIUM CITRATE, REMARK 280 VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 44.04200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 1076 REMARK 465 ALA A 1077 REMARK 465 SER A 1078 REMARK 465 ALA A 1079 REMARK 465 ALA A 1315 REMARK 465 ASP A 1316 REMARK 465 ASP A 1317 REMARK 465 GLU A 1318 REMARK 465 ASP A 1319 REMARK 465 ASP A 1320 REMARK 465 LEU A 1321 REMARK 465 MET A 1322 REMARK 465 GLU A 1323 REMARK 465 GLU A 1324 REMARK 465 ARG A 1325 REMARK 465 MET A 1326 REMARK 465 SER A 1374 REMARK 465 MET A 1375 REMARK 465 ASP A 1376 REMARK 465 ALA A 1377 REMARK 465 LEU A 1378 REMARK 465 ASN A 1379 REMARK 465 GLY B 1076 REMARK 465 ALA B 1077 REMARK 465 SER B 1078 REMARK 465 ALA B 1315 REMARK 465 ASP B 1316 REMARK 465 ASP B 1317 REMARK 465 GLU B 1318 REMARK 465 ASP B 1319 REMARK 465 ASP B 1320 REMARK 465 LEU B 1321 REMARK 465 MET B 1322 REMARK 465 GLU B 1323 REMARK 465 GLU B 1324 REMARK 465 ARG B 1325 REMARK 465 MET B 1326 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A1081 CD NE CZ NH1 NH2 REMARK 470 GLU A1091 CD OE1 OE2 REMARK 470 ASP A1092 CG OD1 OD2 REMARK 470 GLU A1093 OE1 OE2 REMARK 470 ARG A1104 CD NE CZ NH1 NH2 REMARK 470 ARG A1106 CG CD NE CZ NH1 NH2 REMARK 470 GLN A1126 CD OE1 NE2 REMARK 470 LYS A1167 CG CD CE NZ REMARK 470 LYS A1173 NZ REMARK 470 LYS A1224 CE NZ REMARK 470 LYS A1327 CG CD CE NZ REMARK 470 LYS A1351 CD CE NZ REMARK 470 LYS A1362 CE NZ REMARK 470 GLY A1390 C O REMARK 470 ARG B1081 NH1 NH2 REMARK 470 ASN B1090 CG OD1 ND2 REMARK 470 ARG B1104 CD NE CZ NH1 NH2 REMARK 470 GLU B1105 OE1 OE2 REMARK 470 ARG B1106 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1167 CG CD CE NZ REMARK 470 SER B1168 OG REMARK 470 LYS B1173 CE NZ REMARK 470 GLU B1178 CG CD OE1 OE2 REMARK 470 ARG B1247 CD NE CZ NH1 NH2 REMARK 470 ARG B1283 CZ NH1 NH2 REMARK 470 LYS B1327 CG CD CE NZ REMARK 470 LYS B1343 CE NZ REMARK 470 LYS B1351 CD CE NZ REMARK 470 LYS B1362 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A1154 -168.38 -126.57 REMARK 500 SER A1157 -152.59 64.77 REMARK 500 SER A1168 -74.18 71.84 REMARK 500 ASN A1276 -121.08 54.60 REMARK 500 ARG B1106 -8.51 96.33 REMARK 500 SER B1168 -76.84 71.69 REMARK 500 ASN B1276 -119.47 58.83 REMARK 500 ILE B1345 -61.51 -106.53 REMARK 500 ASP B1381 76.65 -153.72 REMARK 500 REMARK 500 REMARK: NULL DBREF 8F8E A 1077 1390 UNP Q9Y4B6 DCAF1_HUMAN 1077 1390 DBREF 8F8E B 1077 1390 UNP Q9Y4B6 DCAF1_HUMAN 1077 1390 SEQADV 8F8E GLY A 1076 UNP Q9Y4B6 EXPRESSION TAG SEQADV 8F8E ALA A 1077 UNP Q9Y4B6 PHE 1077 ENGINEERED MUTATION SEQADV 8F8E ALA A 1079 UNP Q9Y4B6 ARG 1079 ENGINEERED MUTATION SEQADV 8F8E GLY B 1076 UNP Q9Y4B6 EXPRESSION TAG SEQADV 8F8E ALA B 1077 UNP Q9Y4B6 PHE 1077 ENGINEERED MUTATION SEQADV 8F8E ALA B 1079 UNP Q9Y4B6 ARG 1079 ENGINEERED MUTATION SEQRES 1 A 315 GLY ALA SER ALA PHE ARG PRO ILE SER VAL PHE ARG GLU SEQRES 2 A 315 ALA ASN GLU ASP GLU SER GLY PHE THR CYS CYS ALA PHE SEQRES 3 A 315 SER ALA ARG GLU ARG PHE LEU MET LEU GLY THR CYS THR SEQRES 4 A 315 GLY GLN LEU LYS LEU TYR ASN VAL PHE SER GLY GLN GLU SEQRES 5 A 315 GLU ALA SER TYR ASN CYS HIS ASN SER ALA ILE THR HIS SEQRES 6 A 315 LEU GLU PRO SER ARG ASP GLY SER LEU LEU LEU THR SER SEQRES 7 A 315 ALA THR TRP SER GLN PRO LEU SER ALA LEU TRP GLY MET SEQRES 8 A 315 LYS SER VAL PHE ASP MET LYS HIS SER PHE THR GLU ASP SEQRES 9 A 315 HIS TYR VAL GLU PHE SER LYS HIS SER GLN ASP ARG VAL SEQRES 10 A 315 ILE GLY THR LYS GLY ASP ILE ALA HIS ILE TYR ASP ILE SEQRES 11 A 315 GLN THR GLY ASN LYS LEU LEU THR LEU PHE ASN PRO ASP SEQRES 12 A 315 LEU ALA ASN ASN TYR LYS ARG ASN CYS ALA THR PHE ASN SEQRES 13 A 315 PRO THR ASP ASP LEU VAL LEU ASN ASP GLY VAL LEU TRP SEQRES 14 A 315 ASP VAL ARG SER ALA GLN ALA ILE HIS LYS PHE ASP LYS SEQRES 15 A 315 PHE ASN MET ASN ILE SER GLY VAL PHE HIS PRO ASN GLY SEQRES 16 A 315 LEU GLU VAL ILE ILE ASN THR GLU ILE TRP ASP LEU ARG SEQRES 17 A 315 THR PHE HIS LEU LEU HIS THR VAL PRO ALA LEU ASP GLN SEQRES 18 A 315 CYS ARG VAL VAL PHE ASN HIS THR GLY THR VAL MET TYR SEQRES 19 A 315 GLY ALA MET LEU GLN ALA ASP ASP GLU ASP ASP LEU MET SEQRES 20 A 315 GLU GLU ARG MET LYS SER PRO PHE GLY SER SER PHE ARG SEQRES 21 A 315 THR PHE ASN ALA THR ASP TYR LYS PRO ILE ALA THR ILE SEQRES 22 A 315 ASP VAL LYS ARG ASN ILE PHE ASP LEU CYS THR ASP THR SEQRES 23 A 315 LYS ASP CYS TYR LEU ALA VAL ILE GLU ASN GLN GLY SER SEQRES 24 A 315 MET ASP ALA LEU ASN MET ASP THR VAL CYS ARG LEU TYR SEQRES 25 A 315 GLU VAL GLY SEQRES 1 B 315 GLY ALA SER ALA PHE ARG PRO ILE SER VAL PHE ARG GLU SEQRES 2 B 315 ALA ASN GLU ASP GLU SER GLY PHE THR CYS CYS ALA PHE SEQRES 3 B 315 SER ALA ARG GLU ARG PHE LEU MET LEU GLY THR CYS THR SEQRES 4 B 315 GLY GLN LEU LYS LEU TYR ASN VAL PHE SER GLY GLN GLU SEQRES 5 B 315 GLU ALA SER TYR ASN CYS HIS ASN SER ALA ILE THR HIS SEQRES 6 B 315 LEU GLU PRO SER ARG ASP GLY SER LEU LEU LEU THR SER SEQRES 7 B 315 ALA THR TRP SER GLN PRO LEU SER ALA LEU TRP GLY MET SEQRES 8 B 315 LYS SER VAL PHE ASP MET LYS HIS SER PHE THR GLU ASP SEQRES 9 B 315 HIS TYR VAL GLU PHE SER LYS HIS SER GLN ASP ARG VAL SEQRES 10 B 315 ILE GLY THR LYS GLY ASP ILE ALA HIS ILE TYR ASP ILE SEQRES 11 B 315 GLN THR GLY ASN LYS LEU LEU THR LEU PHE ASN PRO ASP SEQRES 12 B 315 LEU ALA ASN ASN TYR LYS ARG ASN CYS ALA THR PHE ASN SEQRES 13 B 315 PRO THR ASP ASP LEU VAL LEU ASN ASP GLY VAL LEU TRP SEQRES 14 B 315 ASP VAL ARG SER ALA GLN ALA ILE HIS LYS PHE ASP LYS SEQRES 15 B 315 PHE ASN MET ASN ILE SER GLY VAL PHE HIS PRO ASN GLY SEQRES 16 B 315 LEU GLU VAL ILE ILE ASN THR GLU ILE TRP ASP LEU ARG SEQRES 17 B 315 THR PHE HIS LEU LEU HIS THR VAL PRO ALA LEU ASP GLN SEQRES 18 B 315 CYS ARG VAL VAL PHE ASN HIS THR GLY THR VAL MET TYR SEQRES 19 B 315 GLY ALA MET LEU GLN ALA ASP ASP GLU ASP ASP LEU MET SEQRES 20 B 315 GLU GLU ARG MET LYS SER PRO PHE GLY SER SER PHE ARG SEQRES 21 B 315 THR PHE ASN ALA THR ASP TYR LYS PRO ILE ALA THR ILE SEQRES 22 B 315 ASP VAL LYS ARG ASN ILE PHE ASP LEU CYS THR ASP THR SEQRES 23 B 315 LYS ASP CYS TYR LEU ALA VAL ILE GLU ASN GLN GLY SER SEQRES 24 B 315 MET ASP ALA LEU ASN MET ASP THR VAL CYS ARG LEU TYR SEQRES 25 B 315 GLU VAL GLY HET XJI A1401 29 HET XJI B1401 29 HET CIT B1402 13 HETNAM XJI (3P)-N-[(1S)-3-AMINO-1-(3-CHLORO-4-FLUOROPHENYL)-3- HETNAM 2 XJI OXOPROPYL]-3-(4-CHLORO-2-FLUOROPHENYL)-1H-PYRAZOLE-4- HETNAM 3 XJI CARBOXAMIDE HETNAM CIT CITRIC ACID FORMUL 3 XJI 2(C19 H14 CL2 F2 N4 O2) FORMUL 5 CIT C6 H8 O7 FORMUL 6 HOH *327(H2 O) HELIX 1 AA1 PRO A 1292 ASP A 1295 5 4 HELIX 2 AA2 PRO B 1292 ASP B 1295 5 4 SHEET 1 AA1 4 ARG A1081 PHE A1086 0 SHEET 2 AA1 4 THR A1382 GLU A1388 -1 O LEU A1386 N ILE A1083 SHEET 3 AA1 4 TYR A1365 ASN A1371 -1 N LEU A1366 O TYR A1387 SHEET 4 AA1 4 ILE A1354 THR A1359 -1 N CYS A1358 O ALA A1367 SHEET 1 AA2 4 PHE A1096 PHE A1101 0 SHEET 2 AA2 4 PHE A1107 THR A1112 -1 O MET A1109 N ALA A1100 SHEET 3 AA2 4 GLN A1116 ASN A1121 -1 O LYS A1118 N LEU A1110 SHEET 4 AA2 4 GLU A1127 ASN A1132 -1 O GLU A1128 N LEU A1119 SHEET 1 AA3 4 ILE A1138 PRO A1143 0 SHEET 2 AA3 4 LEU A1149 ALA A1154 -1 O SER A1153 N THR A1139 SHEET 3 AA3 4 SER A1161 GLY A1165 -1 O TRP A1164 N LEU A1150 SHEET 4 AA3 4 ASP A1171 PHE A1176 -1 O HIS A1174 N LEU A1163 SHEET 1 AA4 4 TYR A1181 PHE A1184 0 SHEET 2 AA4 4 ARG A1191 LYS A1196 -1 O ILE A1193 N GLU A1183 SHEET 3 AA4 4 ILE A1199 ASP A1204 -1 O HIS A1201 N GLY A1194 SHEET 4 AA4 4 LYS A1210 LEU A1214 -1 O LEU A1212 N ILE A1202 SHEET 1 AA5 4 THR A1229 PHE A1230 0 SHEET 2 AA5 4 LEU A1236 ASN A1239 -1 O LEU A1238 N THR A1229 SHEET 3 AA5 4 VAL A1242 ASP A1245 -1 O TRP A1244 N VAL A1237 SHEET 4 AA5 4 GLN A1250 LYS A1254 -1 O HIS A1253 N LEU A1243 SHEET 1 AA6 4 VAL A1265 PHE A1266 0 SHEET 2 AA6 4 GLU A1272 ILE A1275 -1 O ILE A1274 N VAL A1265 SHEET 3 AA6 4 GLU A1278 ASP A1281 -1 O GLU A1278 N ILE A1275 SHEET 4 AA6 4 LEU A1287 THR A1290 -1 O LEU A1288 N ILE A1279 SHEET 1 AA7 4 CYS A1297 PHE A1301 0 SHEET 2 AA7 4 VAL A1307 MET A1312 -1 O TYR A1309 N VAL A1300 SHEET 3 AA7 4 SER A1333 ASN A1338 -1 O ARG A1335 N GLY A1310 SHEET 4 AA7 4 PRO A1344 ASP A1349 -1 O ILE A1348 N PHE A1334 SHEET 1 AA8 4 ARG B1081 ARG B1087 0 SHEET 2 AA8 4 THR B1382 GLU B1388 -1 O LEU B1386 N ILE B1083 SHEET 3 AA8 4 TYR B1365 ASN B1371 -1 N LEU B1366 O TYR B1387 SHEET 4 AA8 4 ILE B1354 THR B1359 -1 N PHE B1355 O ILE B1369 SHEET 1 AA9 4 PHE B1096 PHE B1101 0 SHEET 2 AA9 4 PHE B1107 THR B1112 -1 O MET B1109 N ALA B1100 SHEET 3 AA9 4 GLN B1116 ASN B1121 -1 O LYS B1118 N LEU B1110 SHEET 4 AA9 4 GLU B1127 ASN B1132 -1 O GLU B1128 N LEU B1119 SHEET 1 AB1 4 ILE B1138 PRO B1143 0 SHEET 2 AB1 4 LEU B1149 ALA B1154 -1 O LEU B1151 N GLU B1142 SHEET 3 AB1 4 SER B1161 GLY B1165 -1 O TRP B1164 N LEU B1150 SHEET 4 AB1 4 ASP B1171 PHE B1176 -1 O ASP B1171 N GLY B1165 SHEET 1 AB2 4 TYR B1181 PHE B1184 0 SHEET 2 AB2 4 ARG B1191 LYS B1196 -1 O ILE B1193 N GLU B1183 SHEET 3 AB2 4 ILE B1199 ASP B1204 -1 O HIS B1201 N GLY B1194 SHEET 4 AB2 4 LYS B1210 LEU B1214 -1 O LEU B1214 N ALA B1200 SHEET 1 AB3 4 THR B1229 PHE B1230 0 SHEET 2 AB3 4 LEU B1236 ASN B1239 -1 O LEU B1238 N THR B1229 SHEET 3 AB3 4 VAL B1242 ASP B1245 -1 O TRP B1244 N VAL B1237 SHEET 4 AB3 4 GLN B1250 LYS B1254 -1 O HIS B1253 N LEU B1243 SHEET 1 AB4 4 VAL B1265 PHE B1266 0 SHEET 2 AB4 4 GLU B1272 ILE B1275 -1 O ILE B1274 N VAL B1265 SHEET 3 AB4 4 GLU B1278 ASP B1281 -1 O TRP B1280 N VAL B1273 SHEET 4 AB4 4 LEU B1287 THR B1290 -1 O LEU B1288 N ILE B1279 SHEET 1 AB5 4 CYS B1297 PHE B1301 0 SHEET 2 AB5 4 VAL B1307 LEU B1313 -1 O TYR B1309 N VAL B1300 SHEET 3 AB5 4 PHE B1330 ASN B1338 -1 O ARG B1335 N GLY B1310 SHEET 4 AB5 4 PRO B1344 ASP B1349 -1 O ILE B1348 N PHE B1334 CISPEP 1 GLN A 1158 PRO A 1159 0 -6.92 CISPEP 2 GLN B 1158 PRO B 1159 0 4.81 CRYST1 48.865 88.084 73.562 90.00 97.56 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020465 0.000000 0.002715 0.00000 SCALE2 0.000000 0.011353 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013713 0.00000